The long-term use of aspirin has been shown to significantly reduce the incidence of digestive cancers, new research presented at the 25th UEG (United European Gastroenterology) Week has found.
Tag Archives: pancreatic cancer
Long term aspirin use sharply reduces incidence of digestive cancers – Study
More bad news about extra belly fat – Study
Scientists have found that carrying fat around your middle could be as good an indicator of cancer risk as body mass index (BMI), according to research (link is external)* published in the British Journal of Cancer today (Wednesday).
“However you measure it being overweight or obese can increase the risk of developing certain cancers.” – Dr Julie Sharp, Cancer Research UK It shows that adding about 4.3 inches to the waistline increased the risk of obesity related cancers by 13 per cent.
For bowel cancer, adding around 3.15 inches to the hips is linked to an increased risk of 15 per cent.
Carrying excess body fat can change the levels of sex hormones, such as oestrogen and testosterone, can cause levels of insulin to rise, and lead to inflammation, all of which are factors that have been associated with increased cancer risk. Continue reading
Filed under belly fat, bellyfat, cancer, inflammation
Magnesium Intake May Help Prevent Pancreatic Cancer – IU Researchers
Although I have had three skin cancer operations and my father died of lung caner, I find myself virtually ignorant about pancreatic cancer. Yet, pancreatic cancer is the fourth leading cause of cancer-related death in both men and women in the United States. The overall occurrence of pancreatic cancer has not significantly changed since 2002, but the mortality rate has increased annually from 2002 to 2011, according to the National Cancer Institute.
Indiana University researchers have found that magnesium intake may be beneficial in preventing pancreatic cancer.
Their study, “Magnesium intake and incidence of pancreatic cancer: The VITamins and Lifestyle study,”recently appeared in the British Journal of Cancer.
“Pancreatic cancer is really unique and different from other cancers,” said study co-author Ka He, chair of the Department of Epidemiology and Biostatistics at the IU School of Public Health-Bloomington. “The five-year survival rate is really low, so that makes prevention and identifying risk factors or predictors associated with pancreatic cancer very important.”
Previous studies have found that magnesium is inversely associated with the risk of diabetes, which is a risk factor of pancreatic cancer. But few studies have explored the direct association of magnesium with pancreatic cancer; of those that did, their findings were inconclusive, said Daniel Dibaba, a Ph.D. student at the School of Public Health-Bloomington, who led the IU study.
Using information from the VITamins and Lifestyle study, Dibaba and the other co-authors analyzed an enormous trove of data on over 66,000 men and women, ages 50 to 76, looking at the direct association between magnesium and pancreatic cancer and whether age, gender, body mass index, non-steroidal anti-inflammatory drugs use and magnesium supplementation play a role.
Of those followed, 151 participants developed pancreatic cancer. The study found that every 100-milligrams-per-day decrease in magnesium intake was associated with a 24 percent increase in the occurrence of pancreatic cancer. The study also found that the effects of magnesium on pancreatic cancer did not appear to be modified by age, gender, body mass index or non-steroidal anti-inflammatory drug use, but was limited to those taking magnesium supplements either from a multivitamin or individual supplement.
“For those at a higher risk of pancreatic cancer, adding a magnesium supplement to their diet may prove beneficial in preventing this disease,” Dibaba said. “While more study is needed, the general population should strive to get the daily recommendations of magnesium through diet, such as dark, leafy greens or nuts, to prevent any risk of pancreatic cancer.”
Tony
Filed under cancer, magnesium, Uncategorized
Celery, Artichokes Contain Flavonoids that Kill Human Pancreatic Cancer Cells
According to Johnson, the scientists’ in vitro study in Molecular Nutrition and Food Research is the first to show that apigenin treatment can lead to an increase in interleukin 17s in pancreatic cells, showing its potential relevance in anti-pancreatic cancer activity.
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.
“Apigenin alone induced cell death in two aggressive human pancreatic cancer cell lines. But we received the best results when we pre-treated cancer cells with apigenin for 24 hours, then applied the chemotherapeutic drug gemcitabine for 36 hours,” said Elvira de Mejia, a U of I professor of food chemistry and food toxicology.
The trick seemed to be using the flavonoids as a pre-treatment instead of applying them and the chemotherapeutic drug simultaneously, said Jodee Johnson, a doctoral student in de Mejia’s lab who has since graduated.
“Even though the topic is still controversial, our study indicated that taking antioxidant supplements on the same day as chemotherapeutic drugs may negate the effect of those drugs,”…
View original post 353 more words
Filed under cancer, pancreatic cancer
Wellness Secrets of a SuperAger 